Stay updated on Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.

Latest updates to the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedMinor revision history updates show Revision: v3.3.4 added and Revision: v3.3.3 removed, which do not affect core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA centralized Locations section now lists all study sites by state (Arizona, California, Florida, Indiana, Kentucky, Missouri, New York, Ohio, Oregon, Pennsylvania, Rhode Island, Virginia), replacing the previous per-state location headers. The page also shows an updated Revision: v3.3.3.SummaryDifference1%

- Check45 days agoChange DetectedThe page shows a minor revision update from Revision: v3.3.1 to v3.3.2; no study content, eligibility criteria, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page update represents a minor site version change (v3.3.1 added and v3.2.0 removed) with no visible impact on the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedThe site-wide government funding/operating status banner has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check73 days agoChange DetectedResults reporting information was added to the page, including the Results First Submitted date, QC criteria status, and the Results First Posted date. This makes the study results visible on the record.SummaryDifference0.3%

Stay in the know with updates to Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.